Suppr超能文献

内脏肥胖与直肠腺癌全直肠系膜切除术的结果有关。

Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.

机构信息

Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

出版信息

J Surg Oncol. 2012 Mar 15;105(4):365-70. doi: 10.1002/jso.22031. Epub 2011 Jul 12.

Abstract

BACKGROUND AND OBJECTIVES

General obesity, measured by the body mass index (BMI), increases the technical difficulty of total mesorectal excision (TME) but does not affect oncologic outcomes. The purpose of this study is to compare visceral and general obesity as predictors of outcomes of TME for rectal adenocarcinoma.

METHODS

Adult patients undergoing TME for rectal adenocarcinoma were retrospectively identified. Preoperative computed tomography scans were used to measure abdominal circumference (AC), visceral (VFA), and subcutaneous fat area (SFA). BMI, AC, VFA, SFA, total fat area (TFA, sum of VFA and SFA), and VFA/SFA ratio were examined for association with operative, postoperative, oncologic, and survival outcomes in a univariate analysis model.

RESULTS

Between 1999 and 2009, 113 patients met inclusion criteria. Increasing VFA and VFA/SFA ratio were associated with reduced lymph node retrieval (P = 0.03 and P = 0.009, respectively). The association between increasing VFA/SFA ratio with delayed resumption of oral intake (P = 0.05) and prolonged overall survival (P = 0.003) were also significant. Increasing BMI was associated with improved overall (P = 0.02) but not disease-free survival (P = 0.14).

CONCLUSION

Visceral obesity, measured by VFA/SFA ratio, is a better predictor of postoperative, oncologic, and survival outcomes after TME for rectal adenocarcinoma than general obesity measured by the BMI.

摘要

背景与目的

体质量指数(BMI)衡量的全身性肥胖增加了全直肠系膜切除术(TME)的技术难度,但不影响肿瘤学结果。本研究旨在比较内脏肥胖和全身性肥胖作为预测直肠腺癌 TME 结果的指标。

方法

回顾性确定接受直肠腺癌 TME 的成年患者。使用术前计算机断层扫描来测量腹围(AC)、内脏(VFA)和皮下脂肪面积(SFA)。在单变量分析模型中,检查 BMI、AC、VFA、SFA、总脂肪面积(TFA,VFA 和 SFA 的总和)和 VFA/SFA 比值与手术、术后、肿瘤学和生存结果的相关性。

结果

1999 年至 2009 年间,符合纳入标准的患者有 113 例。VFA 和 VFA/SFA 比值的增加与淋巴结采集减少相关(P=0.03 和 P=0.009)。VFA/SFA 比值与口服摄入恢复延迟(P=0.05)和总生存时间延长(P=0.003)之间的关联也具有统计学意义。BMI 的增加与总生存时间(P=0.02)的改善相关,但与无病生存时间(P=0.14)无关。

结论

与 BMI 衡量的全身性肥胖相比,VFA/SFA 比值衡量的内脏肥胖是预测直肠腺癌 TME 术后、肿瘤学和生存结果的更好指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验